Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.040 GeneticVariation group BEFREE The genotype-phenotype analysis confirmed that ZFHX1B deletions and mutations result in a recognizable facial dysmorphism with a multiple congenital anomaly and mental retardation. 18259761 2008
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.040 Biomarker group BEFREE The SMADIP1 gene recently has been recognized as disease causing in some patients with 2q22 chromosomal rearrangement, resulting in syndromic HSCR with mental retardation, with microcephaly, and with facial dysmorphism. 11595972 2001
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.040 GeneticVariation group BEFREE Here we report the detection of a heterozygous de novo nonsense variant in ZEB2 by whole exome sequencing in a fetus with microphthalmia in addition to cardiac defects and typical MWS facial dysmorphism. 31321886 2019
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.040 GeneticVariation group BEFREE Genotype-phenotype analysis confirmed that ZFHX1B deletions and stop mutations result in a recognizable facial dysmorphism with associated severe mental retardation and variable malformations such as Hirschsprung disease and congenital heart defects. 16053902 2005
Entrez Id: 5308
Gene Symbol: PITX2
PITX2
0.030 GeneticVariation group BEFREE Axenfeld-Rieger syndrome (ARS) patients with PITX2 point mutations exhibit a wide range of clinical features including mild craniofacial dysmorphism and dental anomalies. 18723525 2008
Entrez Id: 54499
Gene Symbol: TMCO1
TMCO1
0.030 GeneticVariation group BEFREE TMCO1 mutations cause craniofacial dysmorphism, skeletal anomalies characterized by multiple malformations of the vertebrae and ribs, and intellectual disability (MIM#614132). 24424126 2014
Entrez Id: 54499
Gene Symbol: TMCO1
TMCO1
0.030 GeneticVariation group BEFREE Recently, a TMCO1 gene mutation was shown to be responsible for an autosomal recessive CFTD syndrome characterized by craniofacial dysmorphism, skeletal anomalies, and intellectual disability. 31102500 2019
Entrez Id: 5308
Gene Symbol: PITX2
PITX2
0.030 Biomarker group BEFREE Affected homozygous zebrafish demonstrated congenital defects consistent with the range of PITX2-associated human phenotypes: abnormal development of the cornea, iris and iridocorneal angle; corneal dermoids; and craniofacial dysmorphism. 29506241 2018
Entrez Id: 54499
Gene Symbol: TMCO1
TMCO1
0.030 GeneticVariation group BEFREE Homozygous frameshift mutation in TMCO1 causes a syndrome with craniofacial dysmorphism, skeletal anomalies, and mental retardation. 20018682 2010
Entrez Id: 5308
Gene Symbol: PITX2
PITX2
0.030 GeneticVariation group BEFREE Human PITX2 mutations are associated with Axenfeld-Rieger syndrome, an autosomal-dominant developmental disorder that involves ocular anterior segment defects, dental hypoplasia, craniofacial dysmorphism and umbilical abnormalities. 22303467 2012
Entrez Id: 2131
Gene Symbol: EXT1
EXT1
0.020 Biomarker group BEFREE The pregnancy was terminated, and a malformed fetus was delivered with characteristic craniofacial dysmorphism of LGS/TRPS type II and CDLS4. 26522117 2015
Entrez Id: 8243
Gene Symbol: SMC1A
SMC1A
0.020 GeneticVariation group BEFREE Relatively few CdLS patients with mutations in SMC1A are known; female carriers have minor facial dysmorphism and cognitive deficiency without major structural abnormalities. 22106055 2012
Entrez Id: 6905
Gene Symbol: TBCE
TBCE
0.020 Biomarker group BEFREE We report a case of severe TBCE-negative phenotypic HRD in a 4-year-old female from India presenting with hypocalcemic seizures due to congenital hypoparathyroidism, extreme microcephaly, growth deficiency, ocular anomalies, and facial dysmorphism. 30055029 2018
Entrez Id: 6834
Gene Symbol: SURF1
SURF1
0.020 Biomarker group BEFREE We report two patients with Leigh syndrome that showed a combination of facial dysmorphism and MRI imaging indicating an SURF1 deficiency, which was confirmed by sequence analysis. 22410471 2012
Entrez Id: 6899
Gene Symbol: TBX1
TBX1
0.020 Biomarker group BEFREE Shprintzen syndrome (velo-cardio-facial, VCFS) is a very rare morbid entity, seen in either familial or sporadic forms, with major clinical findings such as facial dysmorphism, cleft palate, cardiovascular (especially conotruncal-anomalies), mild/moderate mental retardation, or, more commonly, observed learning difficulty. 17117043 2007
Entrez Id: 2316
Gene Symbol: FLNA
FLNA
0.020 GeneticVariation group BEFREE A filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia, and severe constipation reminiscent of cerebro-fronto-facial syndrome. 16299064 2006
Entrez Id: 2131
Gene Symbol: EXT1
EXT1
0.020 Biomarker group BEFREE The Langer-Giedion syndrome (tricho-rhino-phalangeal syndrome type II, TRPS II) is characterized by craniofacial dysmorphism and skeletal abnormalities. 7711731 1995
Entrez Id: 657
Gene Symbol: BMPR1A
BMPR1A
0.020 Biomarker group BEFREE We reason that, even in the absence of juvenile polyposis syndrome, sequencing and copy number analysis of BMPR1A should be considered in patients with (atrioventricular) septal defects, especially when associated with facial dysmorphism and anomalous growth. 22067610 2012
Entrez Id: 7403
Gene Symbol: KDM6A
KDM6A
0.020 GeneticVariation group BEFREE Facial dysmorphism with KDM6A mutations is variable and diagnosis on facial gestalt alone may be difficult in some patients. 24527667 2015
Entrez Id: 657
Gene Symbol: BMPR1A
BMPR1A
0.020 Biomarker group BEFREE These findings provide genetic evidence indicating that optimal Bmpr1a-mediated signaling is essential for NC-derived mesenchymal cell survival in both normal nasal and frontal bone development and suggest that our model is useful for studying some aspects of the molecular etiology of human craniofacial dysmorphism. 22773757 2012
Entrez Id: 8243
Gene Symbol: SMC1A
SMC1A
0.020 Biomarker group BEFREE Cornelia de Lange Syndrome (CdLS) is a congenital autosomal dominant (NIPBL, SMC3 and RAD21) or X-linked (SMC1A and HDAC8) disorder characterized by facial dysmorphism, pre and postnatal growth retardation, developmental delay and/or intellectual disability, and multiorgan involvement. 24874887 2014
Entrez Id: 6812
Gene Symbol: STXBP1
STXBP1
0.020 Biomarker group BEFREE The patients display common clinical features, including intellectual disability with epilepsy, owing to the presence of STXBP1 within the deletion, nail dysplasia and bone malformations, in particular patellar abnormalities attributed to LMX1B deletion, epistaxis and cutaneous-mucous telangiectasias explained by ENG haploinsufficiency and common facial dysmorphism. 26395556 2016
Entrez Id: 6812
Gene Symbol: STXBP1
STXBP1
0.020 GeneticVariation group BEFREE West syndrome is heterogenous, caused by mutations of genes ARX, STXBP1, KCNT1 among others; 16p13.11 and 17q21.31 microdeletions are less frequent, usually associated with intellectual disability and facial dysmorphism. 23929658 2013
Entrez Id: 7403
Gene Symbol: KDM6A
KDM6A
0.020 GeneticVariation group BEFREE We now establish Kabuki syndrome as a neurocristopathy, whereby the majority of clinical features are modeled in mice carrying neural crest (NC) deletion of UTX, including craniofacial dysmorphism, cardiac defects, and postnatal growth retardation. 29073101 2017
Entrez Id: 2316
Gene Symbol: FLNA
FLNA
0.020 GeneticVariation group BEFREE Given that one putative FG locus (FGS2) is situated at Xq28, which is the location of the Filamin A gene (FLNA), and that a Filamin A mutation was reported in a boy with facial dysmorphism and constipation, it was hypothesized that Filamin A mutations could be one cause of FG syndrome. 17632775 2007